Methotrexate
- Product NDC
- 42291-505
- 11-digit product format
- 422910505
- Labeler code
- 42291
- Product ID
- 42291-505_d57d3478-2c9f-3059-e053-2a95a90ae08e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methotrexate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA210040
- Marketing category
- ANDA
- Marketing start
- 2020-10-05
- Marketing end
- 0000-00-00
- Substance
- METHOTREXATE SODIUM
- Active strength
- 3 mg/1
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42291-505 | METHOTREXATE TABLET [AVKARE] | 3 | Legacy NDC | 20240110_b0ed76b6-d9ac-c3dc-e053-2a95a90a49d4.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-505-01 | 42291050501 | 100 TABLET in 1 BOTTLE (42291-505-01) | 100 tablet | 2020-10-05 | 0000-00-00 | No | No | Current |